Favipiravir Market 2020 Report Offers Projections of Potential Impact Due to Corona Virus Outbreak | Fujifilm, Cipla, Shouyuan chemical, HISUN Pharma

Latest ‘ Favipiravir Market’ Report published by Market Expertz gives a detailed analysis of the significant growth trends seen in the industry due to increasing cases of COVID-19 around the globe. The report also includes valuable information pertaining to the growth of the industry, market dynamics, profit margin, market share assessment, gross revenue, and market estimations for the business vertical for the years 2020 to 2027. The study also traces the competitive scenario in the global market to highlight the prominent players in the industry that control a sizable portion of the total market share, along with their product portfolio and prevalent expansion strategies.

Favipiravir (T-705; 6-fluoro-3-hydroxy-2-pyrazinecarboxamide) is an anti-viral agent that selectively and potently inhibits the RNA-dependent RNA polymerase (RdRp) of RNA viruses. Favipiravir was discovered through screening chemical library for anti-viral activity against the influenza virus by Toyama Chemical Co., Ltd. Favipiravir undergoes an intracellular phosphoribosylation to be an active form, favipiravir-RTP (favipiravir ribofuranosyl-5′-triphosphate), which is recognized as a substrate by RdRp, and inhibits the RNA polymerase activity.

Since the catalytic domain of RdRp is conserved among various types of RNA viruses, this mechanism of action underpins a broader spectrum of anti-viral activities of favipiravir. Favipiravir is effective against a wide range of types and subtypes of influenza viruses, including strains resistant to existing anti-influenza drugs. Of note is that favipiravir shows anti-viral activities against other RNA viruses such as arenaviruses, bunyaviruses and filoviruses, all of which are known to cause fatal hemorrhagic fever. These unique anti-viral profiles will make favipiravir a potentially promising drug for specifically untreatable RNA viral infections.

Avail FREE Sample Copy with TOC of the Report to understand the structure of the complete report@https://www.marketexpertz.com/sample-enquiry-form/109045

Fujifilm Toyama Chemical has started a Phase III clinical trial of its antiviral influenza drug Avigan (favipiravir) for the treatment of Covid-19 patients in Japan. Avigan specifically blocks RNA polymerase associated with influenza viral replication. The mechanism is expected to have an antiviral effect on SARS-CoV-2, the novel coronavirus that causes Covid-19.

In Japan, the new Phase III trial will assess Avigan’s safety and efficacy as a potential Covid-19 treatment. According to the study data, the drug was able to shorten the recovery time from 11 days to four days for mild and moderate cases.

Generics drugmaker Beximco (AIM: BXP) says its pharmaceutical division and fellow Bangladesh-based Beacon Pharmaceuticals have developed favipiravir, an antiviral drug that is being used by China to treat COVID-19 patients

In this report, the global Favipiravir market is valued at USD xx billion in 2020 and is expected to reach around USD xx billion by the end of 2027, growing at a CAGR of around xx% between 2019 and 2027.

As per the report, the study offers valuable estimations about the Favipiravir market related to the sales capacity, profit projections, market size, and several other important parameters. The Favipiravir market document also assesses information about the industry segmentation along with the driving forces influencing the remuneration scale of this industry.

Key features of the Favipiravir market:

An overview of the competitive environment of the Favipiravir market, including the leading firms viz.:

Fujifilm Toyama Chemical

Cipla

Hunan Huateng Pharmaceutical Co., Ltd

Lasa Supergenerics Limited

Shouyuan chemical

Zhejiang HISUN Pharmaceuticals Co., Ltd

Toyama Chemical

Information related to the specifications of all the products developed, product applications, and manufacturers are described in the report.

The report approves data related to the organization as well as the position they hold in the industry and the sales that are gained by the manufacturers. Data related to the firm’s price models, along with the gross margins, is also presented in the report.

The sub-segments of the product segment in the Favipiravir market include:

20 Tablets/Box

40 Tablets/Box

Information regarding these products, as well as the market share of these products, is also offered in the report.

• The sales recorded by the products and the revenues produced by the product segments over the predicted time period are included in the report.

Order Your Copy Now (Customized report delivered as per your specific requirement) @https://www.marketexpertz.com/checkout-form/109045

The sub-segments of the application segment in the Favipiravir market include:

Hospital

Clinics

Drug Store

Others

• Details regarding the application landscape of the Favipiravir market related to the applications are elaborated in the report. Along with it, the market share registered by the application segment is also recorded.
• Revenues gained by the applications and the sales projections in the forecast time period are presented in the report.
• Important factors, such as market concentration rate, along with the competition pattern, are highlighted in the report.
• Data referring to the sales channel such as direct and indirect marketing selected by the producers for endorsing their products is seen in the report.

The research report of the Favipiravir market declares that the industry is predicted to account for a decent revenue over the given time period. It includes information with respect to the market dynamics such as growth opportunities, challenges involved in this vertical as well as the circumstances affecting the business domain.

To avail a discount on your copy of the sample report visit@https://www.marketexpertz.com/discount-enquiry-form/109045

Regional segmentation made in the report is explained as follows:

The report provides insights regarding the geographical landscape of the Favipiravir market classified into regions such as:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

The study includes data concerning the sales generated through each zone as well as the registered market share.

Details regarding the growth rate to be registered in the predicted duration are also offered in the report.

Some of the Major Highlights of TOC covers:

Development Trend of Analysis of Favipiravir market

• Global Favipiravir market Trend Analysis
• Global Favipiravir market Size (Volume and Value) Forecast 2020-2025

Marketing Channel

• Direct Marketing
• Indirect Marketing
• FavipiravirCustomers

Market Dynamics

• Market Trends
• Opportunities
• Market Drivers
• Challenges
• Influence Factors

Methodology/Research Approach

• Research Programs/Design
• Market Size Estimation
• Market Breakdown and Data Triangulation
• Data Source

The study can be customized as per the needs of the clients. The customization can be made based on the region that the user is interested in and the companies that exhibit promising growth, which could facilitate lucrative investment.

Browse Complete Report Description and Full TOC@https://www.marketexpertz.com/industry-overview/favipiravir-market

To summarize, the global Favipiravir market report studies the contemporary market to forecast the growth prospects, challenges, opportunities, risks, threats, and the trends observed in the market that can either propel or curtail the growth rate of the industry. The market factors impacting the global sector also include provincial trade policies, international trade disputes, entry barriers, and other regulatory restrictions.

Tags: Favipiravir Market, Favipiravir Market 2020, Favipiravir Market forecast, Favipiravir Market share, Favipiravir Market size, Favipiravir Market trend